These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11005451)

  • 1. Advances in chemotherapy of invasive bladder cancer.
    Akaza H
    Curr Opin Urol; 2000 Sep; 10(5):453-7. PubMed ID: 11005451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy of invasive bladder cancer].
    Kotake T
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2375-82. PubMed ID: 1952956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
    Blick C; Hall P; Pwint T; Al-Terkait F; Crew J; Powles T; Macaulay V; Munro N; Douglas D; Kilbey N; Protheroe A; Chester JD
    Cancer; 2012 Aug; 118(16):3920-7. PubMed ID: 22614698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status of adjuvant chemotherapy of invasive bladder cancer].
    Ozono S; Sasaki K; Watanabe S; Maruyama Y; Ohara S; Babaya K; Yamada K; Hirao Y; Okajima E
    Hinyokika Kiyo; 1991 Dec; 37(12):1589-95. PubMed ID: 1785379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of advanced transitional-cell carcinoma of the bladder.
    Miller RS; Torti FM
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S99-110. PubMed ID: 1394829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of neoadjuvant chemotherapy in invasive bladder cancer.
    Cam K; Yildirim A; Ozveri H; Turkeri L; Akdas A
    Int Urol Nephrol; 2002; 33(1):49-52. PubMed ID: 12090338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M-VAC chemotherapy in the management of locally advanced bladder cancer.
    Skinner DG
    J Urol; 1988 Mar; 139(3):570. PubMed ID: 3343745
    [No Abstract]   [Full Text] [Related]  

  • 8. Intra-arterial administration of methotrexate, adriamycin, and cisplatin as neoadjuvant chemotherapy for bladder cancer.
    Kuriyama M; Takahashi Y; Nagatani Y; Shinoda I; Yamamoto N; Nagai T; Ueno K; Takeuchi T; Maeda S; Isogai K
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S1-4. PubMed ID: 1394808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer.
    Kuroda M; Meguro N; Maeda O; Saiki S; Kinouchi T; Usami M; Kotake T
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S9-13. PubMed ID: 7527736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy in transitional-cell carcinoma of the bladder.
    McLaren DB
    Clin Oncol (R Coll Radiol); 2005 Oct; 17(7):503-7. PubMed ID: 16238137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder.
    Miller RJ; Bahnson RR; Banner B; Ernstoff MS; O'Donnell WF
    Cancer; 1990 Jan; 65(2):207-10. PubMed ID: 2295043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.
    Sternberg CN; Yagoda A; Scher HI
    Prog Clin Biol Res; 1988; 277():45-51. PubMed ID: 3054909
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.
    Lancet; 1999 Aug; 354(9178):533-40. PubMed ID: 10470696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
    Pouessel D; Chevret S; Rolland F; Gravis G; Geoffrois L; Roubaud G; Terrisse S; Boyle H; Chevreau C; Dauba J; Moriceau G; Alexandre I; Deplanque G; Chapelle A; Vauleon E; Colau A; Audenet F; Grellety T; Culine S
    Eur J Cancer; 2016 Feb; 54():69-74. PubMed ID: 26724422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic chemotherapy for transitional cell carcinoma of the urothelium].
    Lehmann J; Retz M; Hack M; Siemer S; Stöckle M
    Onkologie; 2003 Oct; 26 Suppl 4():18-25. PubMed ID: 14605452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group.
    Splinter TA; Scher HI; Denis L; Bukowski R; Simon S; Klimberg I; Soloway M; Vogelzang NJ; van Tinteren H; Herr H
    J Urol; 1992 Mar; 147(3):606-8. PubMed ID: 1538438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
    Keating JP; Zincke H; Hahn RG; Morgan WR
    Prog Clin Biol Res; 1990; 353():119-27. PubMed ID: 2217409
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Locally advanced or metastatic bladder carcinoma. Current aspects of therapy].
    Rübben H; Otto T
    Urologe A; 2001 Nov; 40(6):464-7. PubMed ID: 11760352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.